^
No biomarker
Merkel Cell Carcinoma
avelumab
Sensitive
:
A1
No biomarker
Merkel Cell Carcinoma
pembrolizumab
Sensitive
:
A1
No biomarker
Merkel Cell Carcinoma
EP
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
nivolumab
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
carboplatin
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
carboplatin + etoposide oral
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
topotecan
Sensitive
:
A2
No biomarker
Merkel Cell Carcinoma
AST-008
Sensitive
:
B
ARID2 mutation
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
NTRK1 mutation
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
PD-L1 expression
Merkel Cell Carcinoma
avelumab
Sensitive
:
C3
PD-1 expression
Merkel Cell Carcinoma
Immunotherapy
Sensitive
:
C3
DLL3 expression
Merkel Cell Carcinoma
rovalpituzumab tesirine
Sensitive
:
C4
NCAM1 expression
Merkel Cell Carcinoma
nivolumab
Sensitive
:
C4
TTF-1 expression
Merkel Cell Carcinoma
avelumab
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our